Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 202

Results For "ED"

9539 News Found

All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022
Healthcare | May 29, 2022

All India Institute of Ayurveda launches #YogaSeAyu campaign for International Day of Yoga 2022

The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds


Venus Remedies registers 9.22 % growth in annual sales for FY22
News | May 29, 2022

Venus Remedies registers 9.22 % growth in annual sales for FY22

The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal


Torrent Pharma acquires four brands from Dr Reddy’s
News | May 27, 2022

Torrent Pharma acquires four brands from Dr Reddy’s

The integration and transition of the brands are expected to be completed by June 2022.


Next-gen immunotherapy drug shows promise in several advanced-stage cancers
Biotech | May 27, 2022

Next-gen immunotherapy drug shows promise in several advanced-stage cancers

Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells


Bempedoic acid market in India will get crowded soon:  GlobalData
News | May 27, 2022

Bempedoic acid market in India will get crowded soon: GlobalData

Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe


TN govt. hospital performs robotic-assisted surgery
Hospitals | May 26, 2022

TN govt. hospital performs robotic-assisted surgery

The Da Vinci Robotic-Assisted Surgery system, and Advanced Robotic Surgery Centre was inaugurated early this year


Lumenis OptiLight wins 2022 MedTech Breakthrough Award
News | May 26, 2022

Lumenis OptiLight wins 2022 MedTech Breakthrough Award

For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies


Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr
News | May 26, 2022

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.


Eugia Pharma receives USFDA approval for Pemetrexed
Drug Approval | May 26, 2022

Eugia Pharma receives USFDA approval for Pemetrexed

Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)


Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
Drug Approval | May 26, 2022

Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection

Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)